Indegene Ltd (INDGN) - Net Assets
Based on the latest financial reports, Indegene Ltd (INDGN) has net assets worth Rs31.39 Billion INR (≈ $339.44 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs46.20 Billion ≈ $499.67 Million USD) and total liabilities (Rs14.82 Billion ≈ $160.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INDGN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs31.39 Billion |
| % of Total Assets | 67.93% |
| Annual Growth Rate | N/A |
| 5-Year Change | 310.88% |
| 10-Year Change | N/A |
| Growth Volatility | 40.05 |
Indegene Ltd - Net Assets Trend (2020–2026)
This chart illustrates how Indegene Ltd's net assets have evolved over time, based on quarterly financial data. See INDGN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Indegene Ltd (2020–2026)
The table below shows the annual net assets of Indegene Ltd from 2020 to 2026. For live valuation and market cap data, see market value of Indegene Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs31.39 Billion ≈ $339.44 Million |
+20.00% |
| 2025-03-31 | Rs26.16 Billion ≈ $282.87 Million |
+83.02% |
| 2024-03-31 | Rs14.29 Billion ≈ $154.55 Million |
+34.35% |
| 2023-03-31 | Rs10.64 Billion ≈ $115.04 Million |
+39.25% |
| 2022-03-31 | Rs7.64 Billion ≈ $82.61 Million |
+129.34% |
| 2021-03-31 | Rs3.33 Billion ≈ $36.02 Million |
+2235.45% |
| 2020-03-31 | Rs-155.98 Million ≈ $-1.69 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Indegene Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 135523000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs481.00 Million | 1.53% |
| Other Components | Rs30.91 Billion | 98.47% |
| Total Equity | Rs31.39 Billion | 100.00% |
Indegene Ltd Competitors by Market Cap
The table below lists competitors of Indegene Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Companhia Siderúrgica Nacional
SA:CSNA3
|
$1.35 Billion |
|
Cardinal Energy Ltd
TO:CJ
|
$1.35 Billion |
|
Jinlongyu Group Co Ltd Class A
SHE:002882
|
$1.35 Billion |
|
Techno Electric & Engineering Company Limited
NSE:TECHNOE
|
$1.35 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
$1.35 Billion |
|
Zhongli Science and Technology Group Co Ltd
SHE:002309
|
$1.35 Billion |
|
Odontoprev S.A
SA:ODPV3
|
$1.35 Billion |
|
CONSUN PHARMAC.GR.HD -10
F:C1P
|
$1.35 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Indegene Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 26,156,000,000 to 31,387,000,000, a change of 5,231,000,000 (20.0%).
- Net income of 4,011,000,000 contributed positively to equity growth.
- Dividend payments of 480,000,000 reduced retained earnings.
- New share issuances of 53,000,000 increased equity.
- Other comprehensive income decreased equity by 972,000,000.
- Other factors increased equity by 2,619,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs4.01 Billion | +12.78% |
| Dividends Paid | Rs480.00 Million | -1.53% |
| Share Issuances | Rs53.00 Million | +0.17% |
| Other Comprehensive Income | Rs-972.00 Million | -3.1% |
| Other Changes | Rs2.62 Billion | +8.34% |
| Total Change | Rs- | 20.00% |
Book Value vs Market Value Analysis
This analysis compares Indegene Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | Rs-5.30 | Rs518.60 | x |
| 2021-03-31 | Rs13.56 | Rs518.60 | x |
| 2022-03-31 | Rs31.93 | Rs518.60 | x |
| 2023-03-31 | Rs44.46 | Rs518.60 | x |
| 2024-03-31 | Rs59.82 | Rs518.60 | x |
| 2025-03-31 | Rs109.46 | Rs518.60 | x |
| 2026-03-31 | Rs130.06 | Rs518.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Indegene Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.78%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.43%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 1.47x
- Recent ROE (12.78%) is below the historical average (20.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 8.67% | 1.07x | 0.00x | Rs662.76 Million |
| 2021 | 46.04% | 15.46% | 1.62x | 1.84x | Rs1.17 Billion |
| 2022 | 21.57% | 9.90% | 1.23x | 1.77x | Rs883.72 Million |
| 2023 | 25.02% | 11.54% | 1.05x | 2.07x | Rs1.60 Billion |
| 2024 | 23.56% | 13.00% | 1.02x | 1.78x | Rs1.94 Billion |
| 2025 | 15.55% | 14.32% | 0.85x | 1.27x | Rs1.45 Billion |
| 2026 | 12.78% | 11.43% | 0.76x | 1.47x | Rs872.30 Million |
Industry Comparison
This section compares Indegene Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $51,530,830,000
- Average return on equity (ROE) among peers: 22.79%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Indegene Ltd (INDGN) | Rs31.39 Billion | 0.00% | 0.47x | $1.35 Billion |
| INVENTURUS KNOWLEDGE SO L (IKS) | $6.47 Billion | 36.00% | 0.22x | $3.03 Billion |
| SAGILITY INDIA LIMITED (SAGILITY) | $96.59 Billion | 9.57% | 0.30x | $2.02 Billion |
About Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more